Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of GLH8NDE in Healthy Volunteers
NCT04104997Phase 1Completed
- Sponsor
- GL Pharm Tech Corp
- Start
- Sep 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of recoflavone in dry eye syndrome (DED) (8 arms), sponsored by GL Pharm Tech Corp. Primary endpoints: Adverse events, Vital signs in blood pressure and 13 more. Started Sep 2019; status: completed.
02
Drugs
recoflavone
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04104997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04104997.